Qian Hao

3.2k total citations · 1 hit paper
89 papers, 2.1k citations indexed

About

Qian Hao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qian Hao has authored 89 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 31 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qian Hao's work include Cancer-related Molecular Pathways (19 papers), RNA modifications and cancer (10 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Qian Hao is often cited by papers focused on Cancer-related Molecular Pathways (19 papers), RNA modifications and cancer (10 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Qian Hao collaborates with scholars based in China, United States and Laos. Qian Hao's co-authors include Xiang Zhou, Hua Lu, Guoliang Jiang, Hong Ling, Xiong Chen, Zhijun Dai, Zhen Zhai, Yujiao Deng, Linghui Zhou and Kailiang Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Qian Hao

87 papers receiving 2.1k citations

Hit Papers

Cuproptosis: p53-regulated metabolic cell death? 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qian Hao China 25 1.0k 623 515 412 166 89 2.1k
Feng Zhao China 24 1.2k 1.2× 861 1.4× 785 1.5× 322 0.8× 61 0.4× 76 2.4k
Khalil Helou Sweden 27 1.2k 1.2× 508 0.8× 296 0.6× 514 1.2× 109 0.7× 114 2.2k
David G. Cox United States 28 1.2k 1.2× 517 0.8× 248 0.5× 634 1.5× 128 0.8× 69 2.3k
Sen Zhao China 27 1.0k 1.0× 354 0.6× 430 0.8× 417 1.0× 36 0.2× 131 2.2k
Uma Raju United States 32 1.2k 1.2× 1.0k 1.6× 597 1.2× 484 1.2× 111 0.7× 102 2.7k
Xiaobo Li China 25 635 0.6× 283 0.5× 271 0.5× 274 0.7× 102 0.6× 68 1.6k
Toshima Z. Parris Sweden 20 778 0.8× 379 0.6× 272 0.5× 381 0.9× 77 0.5× 84 1.5k
William H. St. Clair United States 24 1.0k 1.0× 307 0.5× 565 1.1× 487 1.2× 32 0.2× 60 2.1k
Hao G. Nguyen United States 26 881 0.9× 356 0.6× 969 1.9× 307 0.7× 61 0.4× 112 2.3k
Kazuto Ito Japan 32 730 0.7× 466 0.7× 1.7k 3.3× 323 0.8× 397 2.4× 160 3.0k

Countries citing papers authored by Qian Hao

Since Specialization
Citations

This map shows the geographic impact of Qian Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Hao more than expected).

Fields of papers citing papers by Qian Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Hao. The network helps show where Qian Hao may publish in the future.

Co-authorship network of co-authors of Qian Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Hao. A scholar is included among the top collaborators of Qian Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Hao. Qian Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Qian, Yu Gan, Jing Tong, et al.. (2025). p53 transcriptionally activates DCP1B to suppress tumor progression and enhance tumor sensitivity to PI3K blockade in non-small cell lung cancer. Cell Death and Differentiation. 32(9). 1722–1733. 1 indexed citations
2.
Wang, Meng, Yi Zheng, Qian Hao, et al.. (2025). Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis. Journal of Translational Medicine. 23(1). 39–39. 3 indexed citations
3.
Zhang, Xuan, Jun Xu, Jing Hu, et al.. (2024). Cockayne Syndrome Linked to Elevated R-Loops Induced by Stalled RNA Polymerase II during Transcription Elongation. Nature Communications. 15(1). 6031–6031. 7 indexed citations
4.
Cai, Chengcheng, Ric C. H. de Vos, Qian Hao, Johan Bucher, & Guusje Bonnema. (2024). Metabolomic and Transcriptomic Profiles in Diverse Brassica oleracea Crops Provide Insights into the Genetic Regulation of Glucosinolate Profiles. Journal of Agricultural and Food Chemistry. 72(28). 16032–16044. 5 indexed citations
5.
Hao, Qian, Ji Xu, Xin Zhou, et al.. (2024). A Multistage‐Responsive Antibody‐Delivery Strategy to Improve Immunotherapy for NSCLC Brain Metastasis by Ultrasensitive Releasing and Tumor‐Anchoring. Advanced Functional Materials. 34(17). 8 indexed citations
6.
Chen, Xiong, et al.. (2024). AZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis. Science China Life Sciences. 68(1). 204–218. 5 indexed citations
7.
Wang, Lin, et al.. (2024). 1708P The clinical value of tumor-informed minimal residual disease detection in renal cell carcinoma. Annals of Oncology. 35. S1024–S1024. 1 indexed citations
8.
Chen, Xiong, Hong Ling, Qian Hao, & Xiang Zhou. (2023). Cuproptosis: p53-regulated metabolic cell death?. Cell Death and Differentiation. 30(4). 876–884. 177 indexed citations breakdown →
9.
Wang, Jieqiong, Yajie Chen, Canhua Huang, et al.. (2021). Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth. Cancer Research. 81(15). 4041–4053. 13 indexed citations
10.
Hao, Qian, Hai-Tao Yang, Xiaoyu Xu, et al.. (2021). The dissection of R genes and locus Pc5.1 in Phytophthora capsici infection provides a novel view of disease resistance in peppers. BMC Genomics. 22(1). 372–372. 13 indexed citations
11.
Yang, Yang, Lijing Zhang, Jiaojiao Yu, et al.. (2021). A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease. Frontiers in Pharmacology. 12. 735876–735876. 10 indexed citations
12.
Liu, Ying, Yuting Shao, Richard J. Ward, et al.. (2021). The C-terminal of the α1b-adreneroceptor is a key determinant for its structure integrity and biological functions. Bioscience Biotechnology and Biochemistry. 85(5). 1128–1139. 3 indexed citations
13.
Hao, Qian, Yan Zhang, Xiaohong Li, et al.. (2020). Upregulated neuregulin-1 protects against optic nerve injury by regulating the RhoA/cofilin/F-actin axis. Life Sciences. 264. 118283–118283. 6 indexed citations
14.
Deng, Yujiao, Meng Wang, Linghui Zhou, et al.. (2020). Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study. Aging. 12(3). 2545–2583. 59 indexed citations
15.
Liu, Ying, Luyao Chen, Hong Zeng, et al.. (2018). Assessing the real-time activation of the cannabinoid CB1 receptor and the associated structural changes using a FRET biosensor. The International Journal of Biochemistry & Cell Biology. 99. 114–124. 9 indexed citations
16.
Jung, Ji Hoon, Jun‐Ming Liao, Qi Zhang, et al.. (2015). Inauhzin(c) Inactivates c-Myc Independently of p53. Cancer Biology & Therapy. 16(3). 412–419. 13 indexed citations
18.
Hao, Qian, et al.. (2011). Developments in Selective Small Molecule ATP-Targeting the Serine/Threonine Kinase Akt/PKB. Mini-Reviews in Medicinal Chemistry. 11(13). 1093–1107. 14 indexed citations
19.
Li, Xiuying, et al.. (2000). Treatment of 50 patients with Candida albicans vaginitis by cortex sophorae. Chinese Journal of Integrative Medicine. 6(2). 146–147. 1 indexed citations
20.
Fu, Xiaolong, et al.. (1997). Hyperfractionated accelerated radiation therapy for nonsmall cell lung cancer: Clinical phase trial. International Journal of Radiation Oncology*Biology*Physics. 39(3). 545–552. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026